Protocol for a Randomized Phase II/III Double-Blind Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Extended-Release Metformin in Amnestic Mild Cognitive Impairment

Alzheimer Disease and Associated Disorders · Published 2025-04-01 · DOI 10.1097/wad.0000000000000677

Authors being retrieved — see the publisher record. https://doi.org/10.1097/wad.0000000000000677

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2025

Related articles